Loading...
Loading...
Pharmaceutical Importer Β· #11 buyer for Metformin Β· $5.4M import value Β· 112 shipments Β· PHILIPPINES Β· DGFT Verified
I.E. MEDICA INC is the #11 importer of Metformin from India with $5.4M in import value and 112 verified shipments. I.E. MEDICA INC holds a 0.9% market share in Metformin imports based in PHILIPPINES. The company sources from 1 verified supplier across 15 formulations shipped to 1 country. Overall, I.E. MEDICA INC imports 3 pharmaceutical products worth $4.9M across 2 therapeutic categories.

Verified from 112 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INVENTIA HEALTHCARE LIMITED | $5.4M | 112 | 100.0% |
I.E. MEDICA INC sources Metformin from 1 verified Indian supplier based on 112 customs records. The primary supplier is INVENTIA HEALTHCARE LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | APL SWIFT SERVICES (MALTA) LTD., | MALTA | $5.2M | 103 | $50.0K |
| 9 | MYLAN PHARMACEUTICALS INC | UNITED STATES | $4.8M | 95 | $50.0K |
| 11 | I.E. MEDICA INC β | PHILIPPINES | $4.2M | 84 | $50.0K |
| 1 | FORTRESS PHARMACEUTICALS TRADING | GEORGIA | $3.6M | 72 | $50.0K |
| 16 | CSP MYLAN SAS AT CSP-LABO 274 | FRANCE | $3.3M | 65 | $50.0K |
I.E. MEDICA INC ranks #11 among 1,475 Metformin importers from India. Average shipment value of $50.0K compared to the market average of $98.9K. The closest competitors by value are APL SWIFT SERVICES (MALTA) LTD., and MYLAN PHARMACEUTICALS INC.
Destination countries from 112 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $5.4M | 112 | 100.0% |
I.E. MEDICA INC imports Metformin to 1 country. The primary destination is PHILIPPINES receiving 100.0% of shipments worth $5.4M.
| Formulation | Value | Shipments |
|---|---|---|
| NORMAX (METFORMIN HYDROCHLORIDE EXTENDED | $4.2M | 84 |
| LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN H | $200.0K | 4 |
| NORMAX ( METFORMIN HYDROCHLORIDE EXTENDE | $150.0K | 3 |
| NORMAX (METFORMIN HYDROCHLORIDE EXTENDEDRELEASE TABLETS USP 500MG) (ACT. QTY: 82351 X 5X2X10)NOS | $150.0K | 3 |
| NORMAX (METFORMIN HYDROCHLORIDE EXTENDEDRELEASE TABLETS USP 500MG) (ACT.QTY:82041 X 5 X 2 X 10) | $150.0K | 3 |
| NORMAX (METFORMIN HYDROCHLORIDE EXTENDEDRELEASE TABLETS USP 500MG) (ACT.QTY: 30485 X 5 X 2 X 10) | $100.0K | 2 |
| LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN HYDROCHLORIDE SUSTAINED RELEASE 500MG TABLETS)(ACT. QTY: 32700 X 3X10)NOS | $52.9K | 3 |
| LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN HYDROCHLORIDE SUSTAINED RELEASE 500MG TABLETS) (ACT.QTY. 32373 CRTNS X 3X10) |
India exported $145.8M worth of Metformin through 15,000 shipments from 528 suppliers to 160 countries, serving 1,475 buyers globally. I.E. MEDICA INC imports $5.4M of this total, accounting for 0.9% of India's Metformin exports with 112 shipments from PHILIPPINES. This is verified from 112 customs shipment records covering 15 distinct formulations.
I.E. MEDICA INC's average Metformin order value is $48.3K per consignment, based on 112 shipments totaling $5.4M. I.E. MEDICA INC is based in PHILIPPINES and ranks #11 among all Metformin importers from India by value. The company sources from 1 verified supplier in India.
I.E. MEDICA INC sources Metformin from 1 verified Indian supplier: INVENTIA HEALTHCARE LIMITED ($5.4M, 100.0%). This is based on 112 customs records.
I.E. MEDICA INC ranks #11 among 1,475 Metformin importers from India with a 0.9% market share. The top 3 importers are GRANULES PHARMACEUTICALS INC ($27.1M), GRANULES PHARMACEUTICALS, INC. ($23.1M), ZENTIVA PHARMA GMBH ($16.7M). I.E. MEDICA INC processed 112 shipments from PHILIPPINES.
I.E. MEDICA INC also imports these diabetes & endocrine products. Each links to the detailed product page.
I.E. MEDICA INC imports 3 products worth $4.9M. Beyond Metformin, top products include Glimepiride, Ipratropium. View the complete I.E. MEDICA INC profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Metformin β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for I.E. MEDICA INC's Metformin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
I.E. MEDICA INC
Full Company Profile β
3 products Β· $4.9M total trade Β· 2 categories
| $52.4K |
| 3 |
| LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN HYDROCHLORIDE SUSTAINEDRELEASE 500MG TABLETS) (QTY. 32617 CRTNS X 3X10) | $50.0K | 1 |
| NORMAX (METFORMIN HYDROCHLORIDE EXTENDEDRELEASE TABLETS USP 500MG) (ACT. QTY: 82387 X 5X2X10) | $50.0K | 1 |
I.E. MEDICA INC imports 15 distinct Metformin formulations from India. The top formulation is NORMAX (METFORMIN HYDROCHLORIDE EXTENDED with 84 shipments worth $4.2M.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 160+ countries, 1,475+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for I.E. MEDICA INC.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Metformin. For current order-level data, contact TransData Nexus.